Fibrosis
Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act Increases to 27 Members
Published in Food and Drug Law Weekly, November 28th, 2008
PFREA is first of its kind legislation to improve research and awareness of pulmonary fibrosis, a terminal lung disease with no known cause, no FDA approved treatment and no cure. (For more information on PF, visit www.coalitionforpf.org). The PFREA is expected to be re-introduced in the 111th Congress in early 2009. However, additional Members of Congress could be added on as co-sponsors in the current...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
More Articles from Food and Drug Law Weekly
- Life Sciences
AAMC Urges Congress to Stimulate the Economy Through Increased Support for NIH and Medical Education - Mental Health
Studies from Institute of Mental Health Research, Health Research Division have provided new information about mental health - Acorda Therapeutics, Inc.
Acorda Therapeutics Names Thomas C. Wessel, M.D., Ph.D., as Chief Medical Officer - Acusphere, Inc.
Acusphere, Inc. Reports Q3 2008 Financial Results and Business Highlights - American Academy of Dermatology
Is There Really Such a Thing as Hope in a Jar? - Anthrax Vaccines
Studies from W.W. Kwok and co-researchers update current data on anthrax vaccines - More from this issue of Food and Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
